Tags

Type your tag names separated by a space and hit enter

Activation of blood coagulation in plasma from chronic urticaria patients with negative autologous plasma skin test.
J Eur Acad Dermatol Venereol. 2011 Feb; 25(2):201-5.JE

Abstract

BACKGROUND

Skin reactivity to the intradermal injection of autologous serum (autologous serum skin test - ASST) and/or plasma (autologous plasma skin test - APST) is thought to identify chronic urticaria (CU) patients with an autoimmune/autoreactive disease. Immune-mediated inflammation and coagulation are strictly linked, and coagulation activation has been described in CU patients as shown by the elevation of plasma prothrombin fragment F1+2 and, in severe cases, of d-dimer as well.

OBJECTIVE

The aim of this study was to evaluate whether the coagulation cascade is activated in APST-negative CU patients as it has been described in CU patients with an autoreactive disease.

METHODS

A total of 43 adults with CU (M/F 15/28; mean age 43.5 years; 16 APST-negative patients and 27 APST-positive) and 30 healthy subjects were studied. Prothrombin fragment F1+2, d-dimer and C-reactive protein (CRP) plasma levels were measured by ELISA.

RESULTS

Prothrombin fragment F1+2 and d-dimer were elevated in seven of 16 APST-negative CU patients. The activation of the coagulation cascade was associated with disease severity. Men were more prevalent in idiopathic than in autoreactive CU patients (M/F: 10/6 vs. 5/22; P<0.001). In patients with APST-negative CU, mean F1 + 2 level [242.8 ± 33.7 pmol/L (ESM)] was higher than in normal controls (151.8 ± 9.09 pmol/L; P=0.002) but lower than in autoreactive patients (526.2 ± 97.8 pmol/L; P=0.05). Similarly, mean d-dimer level was higher than in normal controls (484.2 ± 148.3 ng/mL vs. 229.5 ± 16.7 ng/mL; P=0.03) but lower than in autoreactive patients (1142.2 ± 317.4 ng/mL; P=0.05). In contrast, mean CRP was lower than in autoreactive patients (1.06 ± 0.32 μg/mL vs. 3.09 ± 0.74 μg/mL; P=0.02) but not different from normal subjects (0.78 ± 0.09 μg/mL; NS).

CONCLUSION

Autologous plasma skin test-negative CU prevails in men; in these patients the coagulation cascade is activated although with a lower intensity than in patients with autoreactive disease.

Authors+Show Affiliations

Ambulatorio di Allergologia, Clinica San Carlo, Paderno Dugnano (MI), Italy. r.asero@libero.itNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article

Language

eng

PubMed ID

20561123

Citation

Asero, R, et al. "Activation of Blood Coagulation in Plasma From Chronic Urticaria Patients With Negative Autologous Plasma Skin Test." Journal of the European Academy of Dermatology and Venereology : JEADV, vol. 25, no. 2, 2011, pp. 201-5.
Asero R, Cugno M, Tedeschi A. Activation of blood coagulation in plasma from chronic urticaria patients with negative autologous plasma skin test. J Eur Acad Dermatol Venereol. 2011;25(2):201-5.
Asero, R., Cugno, M., & Tedeschi, A. (2011). Activation of blood coagulation in plasma from chronic urticaria patients with negative autologous plasma skin test. Journal of the European Academy of Dermatology and Venereology : JEADV, 25(2), 201-5. https://doi.org/10.1111/j.1468-3083.2010.03752.x
Asero R, Cugno M, Tedeschi A. Activation of Blood Coagulation in Plasma From Chronic Urticaria Patients With Negative Autologous Plasma Skin Test. J Eur Acad Dermatol Venereol. 2011;25(2):201-5. PubMed PMID: 20561123.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Activation of blood coagulation in plasma from chronic urticaria patients with negative autologous plasma skin test. AU - Asero,R, AU - Cugno,M, AU - Tedeschi,A, Y1 - 2010/06/17/ PY - 2010/6/22/entrez PY - 2010/6/22/pubmed PY - 2011/4/16/medline SP - 201 EP - 5 JF - Journal of the European Academy of Dermatology and Venereology : JEADV JO - J Eur Acad Dermatol Venereol VL - 25 IS - 2 N2 - BACKGROUND: Skin reactivity to the intradermal injection of autologous serum (autologous serum skin test - ASST) and/or plasma (autologous plasma skin test - APST) is thought to identify chronic urticaria (CU) patients with an autoimmune/autoreactive disease. Immune-mediated inflammation and coagulation are strictly linked, and coagulation activation has been described in CU patients as shown by the elevation of plasma prothrombin fragment F1+2 and, in severe cases, of d-dimer as well. OBJECTIVE: The aim of this study was to evaluate whether the coagulation cascade is activated in APST-negative CU patients as it has been described in CU patients with an autoreactive disease. METHODS: A total of 43 adults with CU (M/F 15/28; mean age 43.5 years; 16 APST-negative patients and 27 APST-positive) and 30 healthy subjects were studied. Prothrombin fragment F1+2, d-dimer and C-reactive protein (CRP) plasma levels were measured by ELISA. RESULTS: Prothrombin fragment F1+2 and d-dimer were elevated in seven of 16 APST-negative CU patients. The activation of the coagulation cascade was associated with disease severity. Men were more prevalent in idiopathic than in autoreactive CU patients (M/F: 10/6 vs. 5/22; P<0.001). In patients with APST-negative CU, mean F1 + 2 level [242.8 ± 33.7 pmol/L (ESM)] was higher than in normal controls (151.8 ± 9.09 pmol/L; P=0.002) but lower than in autoreactive patients (526.2 ± 97.8 pmol/L; P=0.05). Similarly, mean d-dimer level was higher than in normal controls (484.2 ± 148.3 ng/mL vs. 229.5 ± 16.7 ng/mL; P=0.03) but lower than in autoreactive patients (1142.2 ± 317.4 ng/mL; P=0.05). In contrast, mean CRP was lower than in autoreactive patients (1.06 ± 0.32 μg/mL vs. 3.09 ± 0.74 μg/mL; P=0.02) but not different from normal subjects (0.78 ± 0.09 μg/mL; NS). CONCLUSION: Autologous plasma skin test-negative CU prevails in men; in these patients the coagulation cascade is activated although with a lower intensity than in patients with autoreactive disease. SN - 1468-3083 UR - https://www.unboundmedicine.com/medline/citation/20561123/Activation_of_blood_coagulation_in_plasma_from_chronic_urticaria_patients_with_negative_autologous_plasma_skin_test_ L2 - https://doi.org/10.1111/j.1468-3083.2010.03752.x DB - PRIME DP - Unbound Medicine ER -